InnoCare Pharma (SHA:688428, HKG:9969) posted a first-quarter net profit attributable to shareholders of 18.0 million yuan, compared with a loss of 142.4 million yuan a year ago.
Earnings per share stood at 0.01 yuan, versus a loss per share of 0.08 yuan, according to a Tuesday filing with the Shanghai bourse.
The biopharmaceutical company's revenue jumped 130% year over year to 381.3 million yuan from 165.8 million yuan.
Shares of InnoCare Pharma were down 3% on the Shanghai bourse and 4% on the Hong Kong bourse in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。